AAOHN, ACOEM collaborate to study workplace health and safety issues linked with use of marijuana

Published on March 11, 2014 at 2:21 AM · No Comments

The American Association of Occupational Health Nurses (AAOHN) and the American College of Occupational and Environmental Medicine (ACOEM) have announced they will collaborate to study workplace health and safety issues associated with worker impairment from the use of marijuana and other drugs.

Citing changing societal attitudes toward marijuana, including its increasing use for medicinal purposes and new state-decriminalization laws, ACOEM and AAOHN leaders said the occupational health profession can play an important role in helping the U.S. workplace prepare for the potential impacts of these trends.

"Twenty states and the District of Columbia have enacted laws to legalize medical marijuana and two states have approved its recreational use by adults," said AAOHN President Pam Carter, RN. "With growing advocacy, other states seem ready to follow. Mainly because of such rapid change, both of our associations believe it is time to address workplace health and safety concerns when workers have impaired functioning from this and other drugs."

"Marijuana is being viewed as a relatively harmless substance, but this may be a misconception by those who may be unaware of workplace safety issues that can arise when workers are under the influence of marijuana or other drugs," said ACOEM President Ron Loeppke, MD. "To compound the issue, there is a dearth of scientific studies to support the nature of current marijuana products and their effect on workers."

AAOHN and ACOEM will form a collaborative task force over the next several months to examine current science related to marijuana use and determine evidence-based education and recommendations that can be offered to support occupational and environmental professionals who consult with employers regarding workplace health policies.

Source:

The American Association of Occupational Health Nurses

Posted in: Medical Research News | Healthcare News | Pharmaceutical News

Tags: , , , ,

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Telemedicine in action: an interview with Ian Jackson, Managing Director, Imerja